Brokerages expect Stantec Inc. (NYSE:STN) (TSE:STN) to post earnings per share of $0.30 for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Stantec’s earnings, with the highest EPS estimate coming in at $0.30 and the lowest estimate coming in at $0.29. Stantec reported earnings of $0.25 per share during the same quarter last year, which suggests a positive year over year growth rate of 20%. The firm is expected to announce its next earnings results on Thursday, February 28th.
According to Zacks, analysts expect that Stantec will report full-year earnings of $1.27 per share for the current year, with EPS estimates ranging from $1.26 to $1.29. For the next fiscal year, analysts anticipate that the company will report earnings of $1.72 per share, with EPS estimates ranging from $1.63 to $1.86. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research firms that cover Stantec.
Stantec (NYSE:STN) (TSE:STN) last announced its earnings results on Thursday, November 8th. The business services provider reported $0.34 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.41 by ($0.07). The firm had revenue of $690.05 million during the quarter, compared to analysts’ expectations of $699.73 million. Stantec had a return on equity of 10.09% and a net margin of 2.58%.
Several hedge funds have recently bought and sold shares of the company. Bank of New York Mellon Corp lifted its position in shares of Stantec by 65.1% during the 3rd quarter. Bank of New York Mellon Corp now owns 16,023 shares of the business services provider’s stock valued at $398,000 after buying an additional 6,317 shares in the last quarter. Swiss National Bank lifted its position in shares of Stantec by 2.5% during the 3rd quarter. Swiss National Bank now owns 203,670 shares of the business services provider’s stock valued at $5,048,000 after buying an additional 4,900 shares in the last quarter. Toronto Dominion Bank lifted its position in shares of Stantec by 24.3% during the 3rd quarter. Toronto Dominion Bank now owns 192,367 shares of the business services provider’s stock valued at $4,785,000 after buying an additional 37,637 shares in the last quarter. CLARET ASSET MANAGEMENT Corp lifted its position in shares of Stantec by 5.3% during the 3rd quarter. CLARET ASSET MANAGEMENT Corp now owns 82,021 shares of the business services provider’s stock valued at $2,040,000 after buying an additional 4,109 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its position in shares of Stantec by 1.5% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 716,881 shares of the business services provider’s stock valued at $17,814,000 after buying an additional 10,500 shares in the last quarter. 58.51% of the stock is currently owned by hedge funds and other institutional investors.
NYSE:STN traded down $1.76 on Friday, hitting $24.22. The stock had a trading volume of 31,624 shares, compared to its average volume of 27,797. The stock has a market capitalization of $3.02 billion, a price-to-earnings ratio of 17.81 and a beta of 1.23. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.69 and a current ratio of 1.69. Stantec has a 52-week low of $23.95 and a 52-week high of $29.25.
The company also recently announced a quarterly dividend, which will be paid on Thursday, January 10th. Shareholders of record on Friday, December 28th will be given a $0.1049 dividend. The ex-dividend date of this dividend is Thursday, December 27th. This represents a $0.42 annualized dividend and a yield of 1.73%. Stantec’s payout ratio is 30.88%.
Stantec Inc provides professional consulting services in the area of infrastructure and facilities for clients in the public and private sectors in Canada, the United States, and internationally. It operates through four segments: Consulting Services Canada, Consulting Services United States, Consulting Services Global, and Construction Services.
Featured Story: Fundamental Analysis
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Stantec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stantec and related companies with MarketBeat.com's FREE daily email newsletter.